{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T10:42:18Z","timestamp":1776422538382,"version":"3.51.2"},"reference-count":35,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.lfs.2013.01.010","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T03:40:31Z","timestamp":1358998831000},"page":"345-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling"],"prefix":"10.1016","volume":"92","author":[{"given":"Britta","family":"Haenisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wilhelm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Steffens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2013.01.010_bb0005","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.molimm.2005.07.025","article-title":"Human peripheral blood mononuclear cells express GABAA receptor subunits","volume":"43","author":"Alam","year":"2006","journal-title":"Mol Immunol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0010","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","article-title":"New aspects of liver abnormalities as part of the systemic mast cell activation syndrome","volume":"29","author":"Alfter","year":"2009","journal-title":"Liver Int"},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2013.01.010_bb0015","first-page":"R40","article-title":"Evidence for the involvement of peripheral-type benzodiazepine receptors in the inhibitory effect of diazepam, flunitrazepam and 4-chlorodiazepam on the interleukin-8 production in human mast cells","volume":"381","author":"Altarcheh Xifr\u00f3","year":"2010","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0162-3109(99)00046-6","article-title":"Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines","volume":"43","author":"Bidri","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.lfs.2013.01.010_bb0025","first-page":"345","article-title":"Establishment of an immature mast cell line from a patient with mast cell leukemia","volume":"2","author":"Butterfield","year":"1998","journal-title":"Leuk Res"},{"key":"10.1016\/j.lfs.2013.01.010_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/270347a0","article-title":"Continuous growth and differentiation of human myeloid leukaemic cells in suspension culture","volume":"270","author":"Collins","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2013.01.010_bb0035","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/S0022-3565(25)20269-5","article-title":"Identification of a 17-kDa protein associated with the peripheral-type benzodiazepine receptor in vascular and other smooth muscle types","volume":"258","author":"Cox","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.lfs.2013.01.010_bb0040","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jaci.2008.12.005","article-title":"Successful treatment of chronic drug-resistant urticaria with alprazolam","volume":"123","author":"Due\u00f1as-Laita","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0045","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1016\/j.febslet.2012.04.045","article-title":"The bromodomain interaction module","volume":"586","author":"Filippakopoulos","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.lfs.2013.01.010_bb0050","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.bmc.2011.10.080","article-title":"Benzodiazepines and benzotriazepines as protein interaction inhibitors targeting bromodomains of the BET family","volume":"20","author":"Filippakopoulos","year":"2012","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.lfs.2013.01.010_bb0055","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1213\/01.ane.0000166955.97368.80","article-title":"Inhibitory effects of intravenous anesthetics on mast cell function","volume":"101","author":"Fujimoto","year":"2005","journal-title":"Anesth Analg"},{"key":"10.1016\/j.lfs.2013.01.010_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","article-title":"The tyrosine kinase network regulating mast cell activation","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.lfs.2013.01.010_bb0070","doi-asserted-by":"crossref","first-page":"G1104","DOI":"10.1152\/ajpgi.90374.2008","article-title":"Regulatory mechanisms underlying agmatine homeostasis in man","volume":"295","author":"Haenisch","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0065","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.leukres.2010.12.023","article-title":"Effects of exogenous agmatine in human leukemia HMC-1 and HL-60 cells on proliferation, polyamine metabolism and cell cycle","volume":"35","author":"Haenisch","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.lfs.2013.01.010_bb0075","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: a newly recognized disorder with systemic clinical manifestations","volume":"128","author":"Hamilton","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0026-895X(25)10082-5","article-title":"Characterization of ligand binding to mitochondrial benzodiazepine receptors","volume":"35","author":"Hirsch","year":"1989","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0085","doi-asserted-by":"crossref","unstructured":"Jin Z, Mendu SK, Birnir B. GABA is an effective immunomodulatory molecule. Amino Acids in press. http:\/\/dx.doi.org\/10.1007\/s00726-011-1193-7.","DOI":"10.1007\/s00726-011-1193-7"},{"key":"10.1016\/j.lfs.2013.01.010_bb0090","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1182\/blood.V94.7.2333.419k30_2333_2342","article-title":"Demonstration that human mast cells arise from a progenitor cell population that is CD34(+), c-kit(+), and expresses aminopeptidase N (CD13)","volume":"94","author":"Kirshenbaum","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.lfs.2013.01.010_bb0095","unstructured":"Kolck UW. Investigations on the pathogenesis of the systemic mast cell activation syndrome and its impact on heart function. PhD thesis 2009. Bonn, University; URN:nbn:de:hbz:5N-19064; http:\/\/hss.ulb.uni-bonn.de\/2009\/1906\/1906.htm [in German]."},{"issue":"Suppl. 1","key":"10.1016\/j.lfs.2013.01.010_bb0100","first-page":"R43","article-title":"Investigations on the molecular mechanisms mediating the inhibitory effect of benzodiazepines on mast cells","volume":"379","author":"K\u00fcgelgen","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1159\/000138346","article-title":"High-affinity benzodiazepine binding sites on rat peritoneal mast cells and RBL-1 cells: binding characteristics and effects on granule secretion","volume":"36","author":"Miller","year":"1988","journal-title":"Pharmacology"},{"key":"10.1016\/j.lfs.2013.01.010_bb0115","first-page":"A1744","article-title":"Systemische Mastozytose als Grund f\u00fcr chronische gastrointestinale Beschwerden","volume":"102","author":"Molderings","year":"2005","journal-title":"Dtsch Arztebl"},{"key":"10.1016\/j.lfs.2013.01.010_bb0120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/00365520701245744","article-title":"Multiple novel alterations in Kit tyrosine kinase in patients with gastrointestinally pronounced systemic mast cell activation disorder","volume":"42","author":"Molderings","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0110","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0125","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update","volume":"60","author":"Olsen","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.lfs.2013.01.010_bb0130","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA A receptors: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.lfs.2013.01.010_bb0135","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-2999(01)01478-9","article-title":"Binding of [3H]CB 34, a selective ligand for peripheral benzodiazepine receptors, to rat brain membranes","volume":"432","author":"Pisu","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0140","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1006\/abbi.1999.1313","article-title":"Benzodiazepine compounds as inhibitors of the src protein tyrosine kinase: screening of a combinatorial library of 1,4-benzodiazepines","volume":"368","author":"Ramdas","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.lfs.2013.01.010_bb0145","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1523\/JNEUROSCI.5012-10.2011","article-title":"The GABAA receptor alpha+beta-interface: a novel target for subtype selective drugs","volume":"31","author":"Ramerstorfer","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.lfs.2013.01.010_bb0150","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1476-5381.2011.01779.x","article-title":"A novel GABA(A) receptor pharmacology: drugs interacting with the \u03b1+\u03b2-interface","volume":"166","author":"Sieghart","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0014-2999(89)90749-8","article-title":"Effects of benzodiazepines on serotonin release from rat mast cells","volume":"167","author":"Suzuki-Nishimura","year":"1989","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0160","doi-asserted-by":"crossref","first-page":"860","DOI":"10.2174\/156802611795165142","article-title":"Structural requirements to obtain highly potent and selective 18kDa translocator protein (TSPO) ligands","volume":"11","author":"Taliani","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.lfs.2013.01.010_bb0165","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0024-3205(80)90460-9","article-title":"Properties of [3H]diazepam binding to rat peritoneal mast cells","volume":"27","author":"Taniguchi","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.lfs.2013.01.010_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.lfs.2013.01.010_bb0175","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1016\/S0006-2952(96)00558-8","article-title":"Multiple forms and locations for the peripheral-type benzodiazepine receptor","volume":"52","author":"Woods","year":"1996","journal-title":"Biochem Pharmacol"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320513000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:11:16Z","timestamp":1758399076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320513000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":35,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0024320513000180"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2013.01.010","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation into mechanisms mediating the inhibitory effect of 1,4-benzodiazepines on mast cells by gene expression profiling","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2013.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}